Mecasermin, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).
CAT No: 10-101-335
CAS No:68562-41-4
Synonyms/Alias:FK-780; Recombinant human insulin-like growth factor-1; rhIGF-1; Somatomedin-1
Mecasermin, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a synthetic peptide that mimics the activity of naturally occurring IGF-1. As a bioactive protein, it is produced through recombinant DNA technology and is highly valued in scientific research for its ability to replicate the physiological functions of endogenous IGF-1. Mecasermin is characterized by its structural similarity to native IGF-1, allowing it to engage with IGF-1 receptors and activate downstream signaling pathways. Its stability and bioactivity make it a preferred choice for investigators studying growth factor signaling, cellular development, and metabolic regulation. Researchers appreciate the versatility of Mecasermin in both in vitro and in vivo experimental models, where it serves as a reliable tool for elucidating the complex roles of IGF-1 in biological systems.
Cell Growth and Proliferation Studies: Mecasermin is extensively utilized in investigations focused on cellular growth and proliferation. By binding to IGF-1 receptors on the cell surface, it activates intracellular signaling cascades such as the PI3K/Akt and MAPK pathways, which are critical for cell cycle progression and survival. Researchers employ it to dissect the molecular mechanisms underlying tissue development, regeneration, and repair, as well as to model abnormal growth conditions in various cell types. The use of recombinant IGF-1 in these studies provides valuable insights into how growth signals are transduced and regulated at the cellular level.
Metabolic Regulation Research: In the context of metabolic studies, Mecasermin offers a powerful means to probe the regulation of glucose uptake, lipid metabolism, and insulin sensitivity. Scientists use it to investigate the crosstalk between IGF-1 and insulin signaling pathways, exploring how these interactions influence energy balance, adipogenesis, and nutrient partitioning. Its application in metabolic research helps to clarify the role of IGF-1 in maintaining homeostasis and sheds light on the molecular basis of metabolic disorders.
Neurobiology and Neuronal Differentiation: Recombinant IGF-1 is an important tool in neurobiological research, where it is employed to study neuronal survival, differentiation, and synaptic plasticity. It supports the growth and maturation of neuronal cells in culture, enabling researchers to examine the influence of IGF-1 signaling on brain development and function. Investigations using Mecasermin contribute to a deeper understanding of neurotrophic factors, neuronal regeneration, and the molecular processes that govern neural connectivity.
Tissue Engineering and Regenerative Medicine: The application of Mecasermin in tissue engineering and regenerative medicine is driven by its ability to promote cell proliferation and matrix synthesis. Scientists incorporate it into scaffolds and biomaterials to enhance tissue regeneration, particularly in engineered constructs for musculoskeletal, cardiac, and dermal repair. Its capacity to stimulate growth and differentiation makes it an integral component in the design of advanced biomimetic systems and regenerative strategies.
Cancer Biology and Tumorigenesis: In cancer research, Mecasermin is used to investigate the role of IGF-1 signaling in tumor growth, survival, and metastasis. By modulating IGF-1 pathways in cancer cell lines and animal models, researchers can assess the impact of this growth factor on oncogenic transformation, resistance to apoptosis, and the tumor microenvironment. Insights gained from these studies are instrumental in identifying potential molecular targets and understanding the mechanisms that drive malignancy.
In summary, Mecasermin stands out as a versatile and indispensable reagent in modern biomedical research. Its applications span cell growth and proliferation, metabolic regulation, neurobiology, tissue engineering, and cancer biology, offering researchers a robust platform to explore the multifaceted roles of IGF-1 in health and disease. The use of recombinant IGF-1 in experimental systems continues to advance our knowledge of fundamental biological processes and supports the development of innovative approaches in life science research.
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More